Information for "Atezolizumab in locally advanced or metastatic urothelial cancer malignancy a new put evaluation in the Speaking spanish individuals of the IMvigor 210 cohort Two and 211 studies"
From EECH Central
Basic information
| Display title | Atezolizumab in locally advanced or metastatic urothelial cancer malignancy a new put evaluation in the Speaking spanish individuals of the IMvigor 210 cohort Two and 211 studies |
| Default sort key | Atezolizumab in locally advanced or metastatic urothelial cancer malignancy a new put evaluation in the Speaking spanish individuals of the IMvigor 210 cohort Two and 211 studies |
| Page length (in bytes) | 61,644 |
| Page ID | 1368109 |
| Page content language | English (en) |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
Page protection
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
Edit history
| Page creator | Lilaccamp09 (Talk | contribs) |
| Date of page creation | 08:31, 15 April 2024 |
| Latest editor | Lilaccamp09 (Talk | contribs) |
| Date of latest edit | 08:31, 15 April 2024 |
| Total number of edits | 1 |
| Total number of distinct authors | 1 |
| Recent number of edits (within past 90 days) | 1 |
| Recent number of distinct authors | 1 |
